Furthermore, treatment with ONP-302 followed by anti-PD-1 induced a significant increase in the percentage of activated CD8+ and IFN-γ+ T cells within the tumor, hallmarks of effective anti-PD-1 treatment. This evidence concerns the gene IFNG and neoplasm.